Loading Events

« All Events

  • This event has passed.

Workshop: Pharmacotherapy for Smoking Cessation

December 3, 2020 @ 6:30 pm - 7:30 pm

Scott Hunter, MD, MHS

Workshop: Pharmacotherapy for Smoking Cessation

Webinar, via Zoom
Thursday, December 3, 2020
6:30 – 7:30 PM

Faculty: Scott Hunter, MD, MHS
Child, Adolescent, and Addiction Psychiatrist
Los Angeles County Department of Mental Health

CME: The PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™


Tobacco use disorder remains a major cause of preventable death and there has been a resurgence in nicotine use among young people as tobacco products have evolved in recent years. Treatments are effective yet underutilized. Practice guidelines recommend that all smokers trying to quit should use pharmacotherapy as a first-line treatment; however, fewer than one out of every three smokers who try to quit use an FDA-approved smoking cessation medication. Tobacco withdrawal causes clinically significant symptoms of agitation, anxiety, restlessness, and impaired concentration. Medications effectively reduce these withdrawal symptoms and at least double a smoker’s chance of success in quitting. This workshop will review updates in evidence-based treatments for tobacco use disorder, with particular attention to transitional-age youth. These practices will be applied to several case examples to prepare participants for immediate adoption into their practice.

Learning Objectives

  • Demonstrate knowledge of pharmacotherapies for nicotine use disorder treatment, highlighting the safety and efficacy of each.
  • Describe smoking cessation pharmacotherapy dosing and how to enhance its effectiveness in patients.
  • Review the role of counseling in increasing the success of quit attempts.


Accreditation and Designation Statements and Disclosure Report
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and American Academy of Pediatrics – CA2. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

The PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Disclosures
All presenters, planners, editors, or staff reported no relevant relationships with the following statement:
“I, or an immediate family member, do not have at present, or within the last 12 months, nor anticipate having financial interest, arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities.”


December 3, 2020
6:30 pm - 7:30 pm